Download App

Log in to access Online Inquiry
Company Overview More
HUTCHMED China Ltd, formerly Hutchison China Meditech Ltd, is an investment holding company principally engaged in the manufacturing and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Oncology and Immunology segment is engaged in discovering, developing, and commercializing targeted therapies and immunotherapies for the treatment of cancer and immunological diseases, including research and development activities covering drug discovery, development, manufacturing and regulatory functions as well as administrative activities to support research and development operations, also covering sales, marketing, manufacturing and distribution of drug developed from research and development activities. The Other Ventures segment is involved in other commercial businesses including the sales, marketing, manufacturing and distribution of other prescription drugs and over-the-counter pharmaceuticals as well as consumer health products.
CEO: Zhiqiang Du
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 00013 HUTCHMED > Detailed Quotes

00013 HUTCHMED

17.020+1.320+8.41%
Closed 05/20 16:08 CCT
High
17.080
Open
15.620
Turnover
53.38M
Low
15.600
Pre Close
15.700
Volume
3.24M
Market Cap
14.71B
P/E(TTM)
Loss
52wk High
85.800
Shares
864.53M
P/E(Static)
Loss
52wk Low
15.380
Float Cap
14.71B
Bid/Ask %
-58.88%
Historical High
85.800
Shs Float
864.53M
Volume Ratio
2.17
Historical Low
15.380
Dividend TTM
--
Div Yield TTM
--
P/B
1.91
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.38%
Amplitude
9.43%
Avg Price
16.457
Lot Size
500
Float Cap
14.71B
Bid/Ask %
-58.88%
Historical High
85.800
Shs Float
864.53M
Volume Ratio
2.17
Historical Low
15.380
Dividend TTM
--
P/B
1.91
Dividend LFY
--
Turnover Ratio
0.38%
Amplitude
9.43%
Avg Price
16.457
Lot Size
500
Price Forecast

No Data

News

Comment